Blue Bell Private Wealth Management Has Upped Central Securities (CET) Stake; Senator Investment Group LP Has Increased Its Jazz Pharmaceuticals Plc (JAZZ) Position

January 16, 2018 - By Michael Collier

Senator Investment Group Lp increased Jazz Pharmaceuticals Plc (JAZZ) stake by 30% reported in 2017Q3 SEC filing. Senator Investment Group Lp acquired 300,000 shares as Jazz Pharmaceuticals Plc (JAZZ)’s stock rose 8.72%. The Senator Investment Group Lp holds 1.30 million shares with $190.13M value, up from 1.00M last quarter. Jazz Pharmaceuticals Plc now has $9.00B valuation. The stock increased 1.14% or $1.69 during the last trading session, reaching $150.19. About 787,439 shares traded or 62.72% up from the average. Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) has risen 1.25% since January 16, 2017 and is uptrending. It has underperformed by 15.45% the S&P500.

Blue Bell Private Wealth Management Llc increased Central Securities Corp (CET) stake by 537.94% reported in 2017Q3 SEC filing. Blue Bell Private Wealth Management Llc acquired 18,984 shares as Central Securities Corp (CET)’s stock rose 6.56%. The Blue Bell Private Wealth Management Llc holds 22,513 shares with $582,000 value, up from 3,529 last quarter. Central Securities Corp now has $704.39 million valuation. The stock increased 0.89% or $0.25 during the last trading session, reaching $28.39. About 14,041 shares traded. Central Securities Corp. (NYSEMKT:CET) has risen 32.01% since January 16, 2017 and is uptrending. It has outperformed by 15.31% the S&P500.

Investors sentiment increased to 0.67 in 2017 Q3. Its up 0.04, from 0.63 in 2017Q2. It increased, as 3 investors sold CET shares while 12 reduced holdings. 4 funds opened positions while 6 raised stakes. 2.44 million shares or 5.89% more from 2.30 million shares in 2017Q2 were reported. Bulldog Investors Ltd Company reported 368,295 shares stake. Meridian Counsel stated it has 0.2% of its portfolio in Central Securities Corp. (NYSEAMERICAN:CET). Sii Invs Wi holds 21,611 shares or 0.03% of its portfolio. Com Of Vermont, Vermont-based fund reported 2,650 shares. Institute For Wealth Mgmt Limited Co has 34,197 shares. Jbf Capital holds 0.07% of its portfolio in Central Securities Corp. (NYSEAMERICAN:CET) for 25,000 shares. First Manhattan Com owns 33,330 shares or 0% of their US portfolio. 244,001 were reported by 1607 Prns Limited Liability Company. Css Ltd Liability Co Il invested 0.04% in Central Securities Corp. (NYSEAMERICAN:CET). Zuckerman Invest Grp Inc Limited Liability holds 37,275 shares. Signaturefd Limited Liability Com holds 11,059 shares or 0.04% of its portfolio. Northwestern Mutual Wealth Management stated it has 118 shares. Shaker Fincl Serv Lc holds 5.13% or 374,738 shares in its portfolio. Sei Invests Com has invested 0% of its portfolio in Central Securities Corp. (NYSEAMERICAN:CET). Raymond James Fincl Advsr Inc reported 0% of its portfolio in Central Securities Corp. (NYSEAMERICAN:CET).

Since August 10, 2017, it had 0 insider purchases, and 16 sales for $2.80 million activity. 1,000 shares were sold by COZADD BRUCE C, worth $153,520. Shares for $102,077 were sold by McSharry Heather Ann. $94,248 worth of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) was sold by Winningham Rick E. Shares for $94,248 were sold by Sohn Catherine A.. O’Keefe Kenneth W sold $94,248 worth of Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) on Thursday, August 10. Shares for $94,248 were sold by BERNS PAUL L. The insider Treacy Paul sold 1,304 shares worth $186,884.

Among 21 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 16 have Buy rating, 0 Sell and 5 Hold. Therefore 76% are positive. Jazz Pharmaceuticals had 70 analyst reports since August 3, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) on Sunday, December 3 with “Buy” rating. On Wednesday, June 7 the stock rating was maintained by Cowen & Co with “Buy”. As per Wednesday, February 24, the company rating was maintained by Mizuho. The rating was initiated by Leerink Swann on Tuesday, January 2 with “Buy”. As per Monday, April 25, the company rating was upgraded by SunTrust. The rating was maintained by SunTrust on Friday, November 3 with “Buy”. The firm has “Buy” rating by Piper Jaffray given on Thursday, September 14. The firm has “Neutral” rating given on Tuesday, November 10 by Mizuho. The company was initiated on Friday, February 19 by Wells Fargo. The company was initiated on Monday, June 6 by Goldman Sachs.

Investors sentiment decreased to 1.03 in 2017 Q3. Its down 0.36, from 1.39 in 2017Q2. It is negative, as 39 investors sold JAZZ shares while 82 reduced holdings. 31 funds opened positions while 94 raised stakes. 53.58 million shares or 3.54% more from 51.74 million shares in 2017Q2 were reported. Susquehanna Intl Gru Limited Liability Partnership has invested 0% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Icon Advisers holds 109,120 shares. Franklin reported 0.02% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Moreover, Westfield Mgmt Lp has 1.62% invested in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Mitsubishi Ufj Holding Limited holds 0.02% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) for 30 shares. Hutchin Hill Cap Lp owns 8,375 shares. Eaton Vance Mgmt holds 121,735 shares or 0.05% of its portfolio. 3,200 are owned by Meiji Yasuda Asset Mngmt Ltd. Sumitomo Mitsui Asset Mngmt Company Limited, a Japan-based fund reported 4,293 shares. Ranger Investment Lp invested in 0.02% or 2,134 shares. Viking Invsts Limited Partnership accumulated 1.20M shares or 1.13% of the stock. First Republic Invest Management holds 0% or 4,667 shares in its portfolio. Fernwood Inv Mngmt Ltd Liability Com holds 0.3% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) for 3,245 shares. The Connecticut-based Columbus Circle has invested 0.15% in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ). Virtu Financial Ltd Llc holds 0.05% of its portfolio in Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) for 1,992 shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>